Rank | Gene Set | Z-score |
---|---|---|
1 | xenobiotic catabolic process (GO:0042178) | 9.93769266 |
2 | response to nitrosative stress (GO:0051409) | 8.65497181 |
3 | one-carbon compound transport (GO:0019755) | 8.20332377 |
4 | regulation of skeletal muscle contraction (GO:0014819) | 6.13382281 |
5 | cellular glucuronidation (GO:0052695) | 6.08596745 |
6 | glucuronate metabolic process (GO:0019585) | 6.05630248 |
7 | uronic acid metabolic process (GO:0006063) | 6.05630248 |
8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.65170765 |
9 | immunoglobulin mediated immune response (GO:0016064) | 5.55140122 |
10 | nucleotide transmembrane transport (GO:1901679) | 5.42696810 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.26482597 |
12 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.96223102 |
13 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.67968850 |
14 | positive regulation of type 2 immune response (GO:0002830) | 4.64041807 |
15 | glutathione derivative metabolic process (GO:1901685) | 4.58270946 |
16 | glutathione derivative biosynthetic process (GO:1901687) | 4.58270946 |
17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52892960 |
18 | cell wall macromolecule catabolic process (GO:0016998) | 4.49401995 |
19 | regulation of antigen processing and presentation (GO:0002577) | 4.45767141 |
20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.42859636 |
21 | negative regulation of cell killing (GO:0031342) | 4.42859636 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33384026 |
23 | B cell receptor signaling pathway (GO:0050853) | 4.31778772 |
24 | positive regulation of antigen processing and presentation (GO:0002579) | 4.28588340 |
25 | B cell mediated immunity (GO:0019724) | 4.24405523 |
26 | positive thymic T cell selection (GO:0045059) | 4.23826271 |
27 | renal absorption (GO:0070293) | 4.21290607 |
28 | myoblast migration (GO:0051451) | 4.15126602 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.12807596 |
30 | positive regulation of B cell differentiation (GO:0045579) | 4.11040815 |
31 | neutrophil activation involved in immune response (GO:0002283) | 4.04003092 |
32 | regulation of cardioblast proliferation (GO:0003264) | 3.97902805 |
33 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.97902805 |
34 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.97728326 |
35 | bone remodeling (GO:0046849) | 3.94303801 |
36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93587476 |
37 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.91749659 |
38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90099711 |
39 | hemidesmosome assembly (GO:0031581) | 3.82976079 |
40 | cell wall macromolecule metabolic process (GO:0044036) | 3.78759243 |
41 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.76856259 |
42 | gas transport (GO:0015669) | 3.70119429 |
43 | response to peptidoglycan (GO:0032494) | 3.69766711 |
44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.69602815 |
45 | L-ascorbic acid metabolic process (GO:0019852) | 3.69505282 |
46 | replicative senescence (GO:0090399) | 3.68491520 |
47 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.67805553 |
48 | regulation of germinal center formation (GO:0002634) | 3.65471761 |
49 | cell differentiation involved in metanephros development (GO:0072202) | 3.64697265 |
50 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.63984185 |
51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62605819 |
52 | negative regulation of interleukin-12 production (GO:0032695) | 3.58293366 |
53 | surfactant homeostasis (GO:0043129) | 3.56385082 |
54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55449401 |
55 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.53666469 |
56 | pharyngeal system development (GO:0060037) | 3.51185644 |
57 | macrophage activation involved in immune response (GO:0002281) | 3.49965607 |
58 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49559058 |
59 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.48976381 |
60 | negative regulation of JUN kinase activity (GO:0043508) | 3.46891907 |
61 | benzene-containing compound metabolic process (GO:0042537) | 3.41691009 |
62 | androgen biosynthetic process (GO:0006702) | 3.41194954 |
63 | regulation of mast cell degranulation (GO:0043304) | 3.39040887 |
64 | regulation of B cell differentiation (GO:0045577) | 3.37405950 |
65 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.35526712 |
66 | positive regulation of defense response to virus by host (GO:0002230) | 3.34747228 |
67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27088263 |
68 | positive T cell selection (GO:0043368) | 3.26304967 |
69 | defense response to protozoan (GO:0042832) | 3.25353617 |
70 | germinal center formation (GO:0002467) | 3.24707063 |
71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24285750 |
72 | cellular response to exogenous dsRNA (GO:0071360) | 3.23410479 |
73 | regulation of mast cell activation (GO:0033003) | 3.23194235 |
74 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.22857781 |
75 | T-helper 1 type immune response (GO:0042088) | 3.17176684 |
76 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16797842 |
77 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16797842 |
78 | modulation by symbiont of host immune response (GO:0052553) | 3.16797842 |
79 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16797842 |
80 | modulation by symbiont of host defense response (GO:0052031) | 3.16797842 |
81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16797842 |
82 | metanephric mesenchyme development (GO:0072075) | 3.15129328 |
83 | production of molecular mediator of immune response (GO:0002440) | 3.13986204 |
84 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13968184 |
85 | cellular response to interferon-gamma (GO:0071346) | 3.12805504 |
86 | generation of neurons (GO:0048699) | 3.11471830 |
87 | positive regulation of osteoblast proliferation (GO:0033690) | 3.10690515 |
88 | positive regulation of mast cell degranulation (GO:0043306) | 3.10569334 |
89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.10569334 |
90 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.10559557 |
91 | regulation of transmission of nerve impulse (GO:0051969) | 3.09053135 |
92 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.08262789 |
93 | facial nerve structural organization (GO:0021612) | 3.07456354 |
94 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.07243857 |
95 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.06892576 |
96 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.06892576 |
97 | negative thymic T cell selection (GO:0045060) | 3.05953517 |
98 | chemical homeostasis within a tissue (GO:0048875) | 3.04990312 |
99 | regulation of interleukin-8 secretion (GO:2000482) | 3.04755910 |
100 | response to muramyl dipeptide (GO:0032495) | 3.04708583 |
101 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.04579165 |
102 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.04236264 |
103 | regulation of hypersensitivity (GO:0002883) | 3.03852130 |
104 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.03736239 |
105 | response to protozoan (GO:0001562) | 3.03588186 |
106 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.03000007 |
107 | regulation of phospholipase A2 activity (GO:0032429) | 3.02983527 |
108 | seminiferous tubule development (GO:0072520) | 3.00666367 |
109 | detection of external biotic stimulus (GO:0098581) | 3.00190825 |
110 | myeloid cell activation involved in immune response (GO:0002275) | 2.99900798 |
111 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99626480 |
112 | detection of other organism (GO:0098543) | 2.99360402 |
113 | microglial cell activation (GO:0001774) | 2.99282031 |
114 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98990910 |
115 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98990910 |
116 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.98800130 |
117 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.98800130 |
118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98142708 |
119 | neutrophil mediated immunity (GO:0002446) | 2.97242621 |
120 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.96370555 |
121 | detection of bacterium (GO:0016045) | 2.96176455 |
122 | negative regulation of fatty acid transport (GO:2000192) | 2.95713425 |
123 | relaxation of cardiac muscle (GO:0055119) | 2.95585140 |
124 | positive regulation of actin filament depolymerization (GO:0030836) | 2.93948862 |
125 | neutrophil activation (GO:0042119) | 2.93195432 |
126 | phenylpropanoid metabolic process (GO:0009698) | 2.91963926 |
127 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91954782 |
128 | response to interferon-gamma (GO:0034341) | 2.90576085 |
129 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89989576 |
130 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.89393257 |
131 | regulation of T-helper 1 type immune response (GO:0002825) | 2.88494493 |
132 | regulation of interferon-alpha production (GO:0032647) | 2.88119153 |
133 | positive regulation of mast cell activation (GO:0033005) | 2.86881840 |
134 | positive regulation of interferon-alpha production (GO:0032727) | 2.86081838 |
135 | positive regulation of T cell migration (GO:2000406) | 2.86071932 |
136 | dendritic cell chemotaxis (GO:0002407) | 2.85308426 |
137 | regulation of leukocyte degranulation (GO:0043300) | 2.85278407 |
138 | dentate gyrus development (GO:0021542) | 2.85050288 |
139 | sulfate transmembrane transport (GO:1902358) | 2.84533544 |
140 | negative regulation of chemokine production (GO:0032682) | 2.84345924 |
141 | positive regulation of interleukin-17 production (GO:0032740) | 2.84132573 |
142 | negative T cell selection (GO:0043383) | 2.84100118 |
143 | regulation of type 2 immune response (GO:0002828) | 2.82923316 |
144 | diterpenoid biosynthetic process (GO:0016102) | 2.82910728 |
145 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.82146649 |
146 | regulation of T cell migration (GO:2000404) | 2.81635830 |
147 | glutathione metabolic process (GO:0006749) | 2.81593621 |
148 | superoxide anion generation (GO:0042554) | 2.81536039 |
149 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.80386475 |
150 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79968254 |
151 | energy homeostasis (GO:0097009) | 2.79897585 |
152 | nucleotide transport (GO:0006862) | 2.78408305 |
153 | interferon-gamma secretion (GO:0072643) | 2.78267758 |
154 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.78088006 |
155 | mast cell activation (GO:0045576) | 2.78044302 |
156 | type I interferon signaling pathway (GO:0060337) | 2.77996979 |
157 | cellular response to type I interferon (GO:0071357) | 2.77996979 |
158 | response to type I interferon (GO:0034340) | 2.77509683 |
159 | response to host immune response (GO:0052572) | 2.76740599 |
160 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76740599 |
161 | response to caffeine (GO:0031000) | 2.76587615 |
162 | response to interferon-beta (GO:0035456) | 2.76503231 |
163 | granulocyte activation (GO:0036230) | 2.75353336 |
164 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.75010709 |
165 | regulation of interleukin-12 production (GO:0032655) | 2.74784955 |
166 | regulation of T-helper cell differentiation (GO:0045622) | 2.74558123 |
167 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74360347 |
168 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.72474283 |
169 | detection of biotic stimulus (GO:0009595) | 2.71715025 |
170 | kidney morphogenesis (GO:0060993) | 2.71615545 |
171 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.71582772 |
172 | positive regulation of chemokine secretion (GO:0090197) | 2.71398358 |
173 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.71172304 |
174 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70923057 |
175 | positive regulation of B cell activation (GO:0050871) | 2.70714767 |
176 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.70202141 |
177 | T cell selection (GO:0045058) | 2.69922645 |
178 | negative regulation of gluconeogenesis (GO:0045721) | 2.66564786 |
179 | DNA damage response, detection of DNA damage (GO:0042769) | 2.66262745 |
180 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66128488 |
181 | kidney mesenchyme development (GO:0072074) | 2.63629194 |
182 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.62233632 |
183 | cell proliferation involved in kidney development (GO:0072111) | 2.61947892 |
184 | desmosome organization (GO:0002934) | 2.61582034 |
185 | sulfate transport (GO:0008272) | 2.61118340 |
186 | regulation of chemokine secretion (GO:0090196) | 2.60510876 |
187 | androgen metabolic process (GO:0008209) | 2.59136514 |
188 | mesenchyme morphogenesis (GO:0072132) | 2.58496675 |
189 | lipoxygenase pathway (GO:0019372) | 2.56191150 |
190 | regulation of immunoglobulin secretion (GO:0051023) | 2.53161849 |
191 | polyol transport (GO:0015791) | 2.51745977 |
192 | organ or tissue specific immune response (GO:0002251) | 2.51649822 |
193 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.51649069 |
194 | negative regulation of lipid storage (GO:0010888) | 2.50147574 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.79733409 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.62191344 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.39130452 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.32981342 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09183660 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.71822540 |
7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.41028182 |
8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.40685767 |
9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.36907595 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17825797 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.94008995 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88867437 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.84874677 |
14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.74723642 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.42875767 |
16 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.38733292 |
17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28725585 |
18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24683955 |
19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.22959649 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20518502 |
21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.18899312 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17574576 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07625818 |
24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01315767 |
25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.00903558 |
26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.00838651 |
27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99601798 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94428607 |
29 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.93940186 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85437460 |
31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82034826 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81524416 |
33 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.81318513 |
34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.78458166 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77618577 |
36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76517848 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.75713017 |
38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.75713017 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75059733 |
40 | GATA3_26560356_Chip-Seq_TH2_Human | 1.73305361 |
41 | MYB_26560356_Chip-Seq_TH1_Human | 1.71000444 |
42 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.66740964 |
43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65953101 |
44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62221459 |
45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62192553 |
46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62167712 |
47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60072121 |
48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59254294 |
49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.59186734 |
50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55704987 |
51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54235720 |
52 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53386237 |
53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53262411 |
54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53262411 |
55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52816823 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52676510 |
57 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.49880326 |
58 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49646775 |
59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47604354 |
60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46785829 |
61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46627063 |
62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.45574058 |
63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45229083 |
64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43450967 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42245914 |
66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41470393 |
67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41201918 |
68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39513441 |
69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38988131 |
70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37824263 |
71 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.36838225 |
72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36648574 |
73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34241212 |
74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33584793 |
75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33330213 |
76 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32270648 |
77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32004243 |
78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31286252 |
79 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30617136 |
80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30282633 |
81 | MAF_26560356_Chip-Seq_TH1_Human | 1.24440125 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24018951 |
83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23323030 |
84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22672220 |
85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19781833 |
86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19229116 |
87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18737918 |
88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17865416 |
89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17378212 |
90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16980066 |
91 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16868132 |
92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16217439 |
93 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16171352 |
94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15536211 |
95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15191826 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15101091 |
97 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14466192 |
98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14092730 |
99 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11352634 |
100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11302487 |
101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10693097 |
102 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.09963777 |
103 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09637206 |
104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07387278 |
105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06965411 |
106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06863858 |
107 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06773816 |
108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06631120 |
109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06631120 |
110 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05714673 |
111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05663523 |
112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04282011 |
113 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03924913 |
114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03856732 |
115 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03836935 |
116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03290813 |
117 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.02450399 |
118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02164116 |
119 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01557604 |
120 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01049543 |
121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00700495 |
122 | MYC_22102868_ChIP-Seq_BL_Human | 1.00157313 |
123 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00010116 |
124 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.99189143 |
125 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98478608 |
126 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96402157 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95978521 |
128 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.95893808 |
129 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95443157 |
130 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94875306 |
131 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94827564 |
132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94479233 |
133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94078644 |
134 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94077494 |
135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93877029 |
136 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.92768284 |
137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92490970 |
138 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.91669048 |
139 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.91645718 |
140 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.91295757 |
141 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91022558 |
142 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90939781 |
143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90615129 |
144 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.90282028 |
145 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.89684365 |
146 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89416327 |
147 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89416327 |
148 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89416327 |
149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88680816 |
150 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.87910217 |
151 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86986885 |
152 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86860012 |
153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86430749 |
154 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86272992 |
155 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85105147 |
156 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85100141 |
157 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83030907 |
158 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82637284 |
159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82492609 |
160 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81837294 |
161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80479984 |
162 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79725658 |
163 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78315598 |
164 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76532915 |
165 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75165726 |
166 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74666258 |
167 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74510072 |
168 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73984593 |
169 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.73569760 |
170 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73333574 |
171 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.73067149 |
172 | GATA3_26560356_Chip-Seq_TH1_Human | 0.72696386 |
173 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71039467 |
174 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70605899 |
175 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68432383 |
176 | P300_27268052_Chip-Seq_Bcells_Human | 0.67428619 |
177 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66594667 |
178 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65246888 |
179 | MAF_26560356_Chip-Seq_TH2_Human | 0.65067596 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008789_abnormal_olfactory_epithelium | 4.89171048 |
2 | MP0005394_taste/olfaction_phenotype | 4.30968433 |
3 | MP0005499_abnormal_olfactory_system | 4.30968433 |
4 | MP0010030_abnormal_orbit_morphology | 4.02661874 |
5 | MP0002254_reproductive_system_inflammat | 3.90961229 |
6 | MP0003303_peritoneal_inflammation | 3.76855084 |
7 | MP0002877_abnormal_melanocyte_morpholog | 3.72461748 |
8 | MP0000566_synostosis | 3.51925352 |
9 | MP0001346_abnormal_lacrimal_gland | 3.48645524 |
10 | MP0000678_abnormal_parathyroid_gland | 3.33896020 |
11 | MP0001800_abnormal_humoral_immune | 3.04374673 |
12 | MP0002148_abnormal_hypersensitivity_rea | 3.03919297 |
13 | MP0005671_abnormal_response_to | 3.01330200 |
14 | MP0003436_decreased_susceptibility_to | 2.94491403 |
15 | MP0000762_abnormal_tongue_morphology | 2.80669876 |
16 | MP0005000_abnormal_immune_tolerance | 2.79416996 |
17 | MP0003172_abnormal_lysosome_physiology | 2.74122663 |
18 | MP0006292_abnormal_olfactory_placode | 2.68303612 |
19 | MP0002452_abnormal_antigen_presenting | 2.65380876 |
20 | MP0002723_abnormal_immune_serum | 2.60579894 |
21 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54905084 |
22 | MP0000685_abnormal_immune_system | 2.50902326 |
23 | MP0005025_abnormal_response_to | 2.47856559 |
24 | MP0003191_abnormal_cellular_cholesterol | 2.38383133 |
25 | MP0001984_abnormal_olfaction | 2.35760632 |
26 | MP0002420_abnormal_adaptive_immunity | 2.34212606 |
27 | MP0001819_abnormal_immune_cell | 2.34166487 |
28 | MP0005464_abnormal_platelet_physiology | 2.22619547 |
29 | MP0003186_abnormal_redox_activity | 2.17897120 |
30 | MP0009278_abnormal_bone_marrow | 2.14615863 |
31 | MP0004264_abnormal_extraembryonic_tissu | 1.98726755 |
32 | MP0002277_abnormal_respiratory_mucosa | 1.97909355 |
33 | MP0005397_hematopoietic_system_phenotyp | 1.95878414 |
34 | MP0001545_abnormal_hematopoietic_system | 1.95878414 |
35 | MP0000613_abnormal_salivary_gland | 1.89127371 |
36 | MP0000465_gastrointestinal_hemorrhage | 1.85424639 |
37 | MP0000716_abnormal_immune_system | 1.81729787 |
38 | MP0003763_abnormal_thymus_physiology | 1.81039538 |
39 | MP0005248_abnormal_Harderian_gland | 1.80739140 |
40 | MP0004782_abnormal_surfactant_physiolog | 1.80056893 |
41 | MP0002233_abnormal_nose_morphology | 1.78612818 |
42 | MP0000049_abnormal_middle_ear | 1.78582250 |
43 | MP0005646_abnormal_pituitary_gland | 1.77478929 |
44 | MP0002398_abnormal_bone_marrow | 1.77127668 |
45 | MP0001845_abnormal_inflammatory_respons | 1.75639861 |
46 | MP0003941_abnormal_skin_development | 1.73321938 |
47 | MP0009379_abnormal_foot_pigmentation | 1.72704983 |
48 | MP0002132_abnormal_respiratory_system | 1.66359222 |
49 | MP0002098_abnormal_vibrissa_morphology | 1.64691493 |
50 | MP0001533_abnormal_skeleton_physiology | 1.62547383 |
51 | MP0003787_abnormal_imprinting | 1.61795209 |
52 | MP0000689_abnormal_spleen_morphology | 1.59796363 |
53 | MP0003300_gastrointestinal_ulcer | 1.55787160 |
54 | MP0002249_abnormal_larynx_morphology | 1.54277847 |
55 | MP0005310_abnormal_salivary_gland | 1.52916939 |
56 | MP0003866_abnormal_defecation | 1.51851228 |
57 | MP0004947_skin_inflammation | 1.50885744 |
58 | MP0002396_abnormal_hematopoietic_system | 1.50563737 |
59 | MP0003786_premature_aging | 1.49595632 |
60 | MP0000467_abnormal_esophagus_morphology | 1.49433199 |
61 | MP0003806_abnormal_nucleotide_metabolis | 1.47903743 |
62 | MP0008469_abnormal_protein_level | 1.45623813 |
63 | MP0003656_abnormal_erythrocyte_physiolo | 1.44434984 |
64 | MP0002429_abnormal_blood_cell | 1.42859736 |
65 | MP0001188_hyperpigmentation | 1.41560293 |
66 | MP0002139_abnormal_hepatobiliary_system | 1.39915739 |
67 | MP0003183_abnormal_peptide_metabolism | 1.39594723 |
68 | MP0002722_abnormal_immune_system | 1.38265169 |
69 | MP0008004_abnormal_stomach_pH | 1.36380074 |
70 | MP0005058_abnormal_lysosome_morphology | 1.35173096 |
71 | MP0005409_darkened_coat_color | 1.32281315 |
72 | MP0001501_abnormal_sleep_pattern | 1.29927402 |
73 | MP0002138_abnormal_hepatobiliary_system | 1.29408211 |
74 | MP0003724_increased_susceptibility_to | 1.29387069 |
75 | MP0003195_calcinosis | 1.28478156 |
76 | MP0003075_altered_response_to | 1.27816314 |
77 | MP0004808_abnormal_hematopoietic_stem | 1.23151118 |
78 | MP0000372_irregular_coat_pigmentation | 1.21664745 |
79 | MP0001873_stomach_inflammation | 1.21047343 |
80 | MP0009250_abnormal_appendicular_skeleto | 1.20471542 |
81 | MP0005075_abnormal_melanosome_morpholog | 1.20397770 |
82 | MP0000569_abnormal_digit_pigmentation | 1.20348088 |
83 | MP0000383_abnormal_hair_follicle | 1.20162783 |
84 | MP0005377_hearing/vestibular/ear_phenot | 1.19120469 |
85 | MP0003878_abnormal_ear_physiology | 1.19120469 |
86 | MP0001270_distended_abdomen | 1.18612934 |
87 | MP0002060_abnormal_skin_morphology | 1.14644877 |
88 | MP0002998_abnormal_bone_remodeling | 1.12741829 |
89 | MP0004134_abnormal_chest_morphology | 1.12583034 |
90 | MP0000681_abnormal_thyroid_gland | 1.10127763 |
91 | MP0002876_abnormal_thyroid_physiology | 1.09377452 |
92 | MP0000604_amyloidosis | 1.09361065 |
93 | MP0001986_abnormal_taste_sensitivity | 1.08901244 |
94 | MP0009764_decreased_sensitivity_to | 1.06240145 |
95 | MP0002234_abnormal_pharynx_morphology | 1.05667684 |
96 | MP0000534_abnormal_ureter_morphology | 1.05533014 |
97 | MP0008995_early_reproductive_senescence | 1.04088531 |
98 | MP0009333_abnormal_splenocyte_physiolog | 1.03793261 |
99 | MP0010368_abnormal_lymphatic_system | 1.03041165 |
100 | MP0009785_altered_susceptibility_to | 1.02592519 |
101 | MP0009840_abnormal_foam_cell | 1.01136595 |
102 | MP0003136_yellow_coat_color | 0.99058706 |
103 | MP0001905_abnormal_dopamine_level | 0.98934037 |
104 | MP0002938_white_spotting | 0.97178053 |
105 | MP0001851_eye_inflammation | 0.94931689 |
106 | MP0003937_abnormal_limbs/digits/tail_de | 0.94400109 |
107 | MP0004381_abnormal_hair_follicle | 0.94308905 |
108 | MP0001835_abnormal_antigen_presentation | 0.94188922 |
109 | MP0000343_altered_response_to | 0.94135227 |
110 | MP0004043_abnormal_pH_regulation | 0.93066679 |
111 | MP0000703_abnormal_thymus_morphology | 0.93036639 |
112 | MP0005164_abnormal_response_to | 0.92447505 |
113 | MP0000538_abnormal_urinary_bladder | 0.92083093 |
114 | MP0000647_abnormal_sebaceous_gland | 0.91892283 |
115 | MP0003755_abnormal_palate_morphology | 0.90708256 |
116 | MP0002177_abnormal_outer_ear | 0.90415775 |
117 | MP0003828_pulmonary_edema | 0.89390329 |
118 | MP0005174_abnormal_tail_pigmentation | 0.88249470 |
119 | MP0000015_abnormal_ear_pigmentation | 0.87876540 |
120 | MP0010678_abnormal_skin_adnexa | 0.86992411 |
121 | MP0001663_abnormal_digestive_system | 0.86978672 |
122 | MP0002009_preneoplasia | 0.86265834 |
123 | MP0005171_absent_coat_pigmentation | 0.86231673 |
124 | MP0009763_increased_sensitivity_to | 0.85615270 |
125 | MP0003690_abnormal_glial_cell | 0.83609541 |
126 | MP0003252_abnormal_bile_duct | 0.83567726 |
127 | MP0009765_abnormal_xenobiotic_induced | 0.83076698 |
128 | MP0001186_pigmentation_phenotype | 0.82880124 |
129 | MP0004147_increased_porphyrin_level | 0.82554449 |
130 | MP0000249_abnormal_blood_vessel | 0.81924487 |
131 | MP0000627_abnormal_mammary_gland | 0.79984995 |
132 | MP0008872_abnormal_physiological_respon | 0.79611850 |
133 | MP0001216_abnormal_epidermal_layer | 0.79440286 |
134 | MP0000579_abnormal_nail_morphology | 0.78489407 |
135 | MP0005165_increased_susceptibility_to | 0.78311191 |
136 | MP0005408_hypopigmentation | 0.77530823 |
137 | MP0009053_abnormal_anal_canal | 0.76917292 |
138 | MP0004883_abnormal_blood_vessel | 0.76868816 |
139 | MP0002751_abnormal_autonomic_nervous | 0.76475688 |
140 | MP0003566_abnormal_cell_adhesion | 0.76448924 |
141 | MP0005166_decreased_susceptibility_to | 0.74939401 |
142 | MP0008007_abnormal_cellular_replicative | 0.72532034 |
143 | MP0003890_abnormal_embryonic-extraembry | 0.70687399 |
144 | MP0010155_abnormal_intestine_physiology | 0.70576548 |
145 | MP0001177_atelectasis | 0.70293396 |
146 | MP0002933_joint_inflammation | 0.70282725 |
147 | MP0001790_abnormal_immune_system | 0.68469018 |
148 | MP0005387_immune_system_phenotype | 0.68469018 |
149 | MP0002095_abnormal_skin_pigmentation | 0.67968841 |
150 | MP0002166_altered_tumor_susceptibility | 0.67460728 |
151 | MP0000858_altered_metastatic_potential | 0.67343942 |
152 | MP0002136_abnormal_kidney_physiology | 0.67217557 |
153 | MP0003448_altered_tumor_morphology | 0.67177695 |
154 | MP0005508_abnormal_skeleton_morphology | 0.67028177 |
155 | MP0005390_skeleton_phenotype | 0.67004646 |
156 | MP0005167_abnormal_blood-brain_barrier | 0.66764082 |
157 | MP0006082_CNS_inflammation | 0.66189410 |
158 | MP0000163_abnormal_cartilage_morphology | 0.65820105 |
159 | MP0002419_abnormal_innate_immunity | 0.64844969 |
160 | MP0000537_abnormal_urethra_morphology | 0.63603311 |
161 | MP0005645_abnormal_hypothalamus_physiol | 0.62508505 |
162 | MP0001764_abnormal_homeostasis | 0.61932866 |
163 | MP0002116_abnormal_craniofacial_bone | 0.61746945 |
164 | MP0002405_respiratory_system_inflammati | 0.61576123 |
165 | MP0003045_fibrosis | 0.61379966 |
166 | MP0001853_heart_inflammation | 0.61072318 |
167 | MP0003453_abnormal_keratinocyte_physiol | 0.60566210 |
168 | MP0008260_abnormal_autophagy | 0.60400290 |
169 | MP0002133_abnormal_respiratory_system | 0.59365515 |
170 | MP0001765_abnormal_ion_homeostasis | 0.57468002 |
171 | MP0002332_abnormal_exercise_endurance | 0.54766247 |
172 | MP0000371_diluted_coat_color | 0.54593540 |
173 | MP0002019_abnormal_tumor_incidence | 0.54407245 |
174 | MP0001664_abnormal_digestion | 0.53407388 |
175 | MP0009643_abnormal_urine_homeostasis | 0.51527216 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Urethral obstruction (HP:0000796) | 5.76276344 |
2 | Stomach cancer (HP:0012126) | 5.69430904 |
3 | Lip pit (HP:0100267) | 4.84942412 |
4 | Myositis (HP:0100614) | 4.46329834 |
5 | Agammaglobulinemia (HP:0004432) | 4.38342213 |
6 | Onycholysis (HP:0001806) | 4.18058290 |
7 | Recurrent bacterial skin infections (HP:0005406) | 4.03005004 |
8 | Recurrent abscess formation (HP:0002722) | 3.95734964 |
9 | Vasculitis (HP:0002633) | 3.74429642 |
10 | Meningitis (HP:0001287) | 3.74337937 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.69203319 |
12 | Distal lower limb muscle weakness (HP:0009053) | 3.61616242 |
13 | Stomatitis (HP:0010280) | 3.59969135 |
14 | Neoplasm of the adrenal cortex (HP:0100641) | 3.54556784 |
15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48432603 |
16 | Colitis (HP:0002583) | 3.48230382 |
17 | Pulmonary infiltrates (HP:0002113) | 3.47479550 |
18 | Alveolar cell carcinoma (HP:0006519) | 3.39852182 |
19 | Prostate neoplasm (HP:0100787) | 3.38700182 |
20 | Panhypogammaglobulinemia (HP:0003139) | 3.37966644 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29231976 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29231976 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29231976 |
24 | Milia (HP:0001056) | 3.27020601 |
25 | Gastrointestinal stroma tumor (HP:0100723) | 3.26370924 |
26 | Recurrent sinusitis (HP:0011108) | 3.26078322 |
27 | Recurrent fungal infections (HP:0002841) | 3.24036421 |
28 | Increased cerebral lipofuscin (HP:0011813) | 3.19874003 |
29 | Inflammation of the large intestine (HP:0002037) | 3.15517749 |
30 | Right ventricular cardiomyopathy (HP:0011663) | 3.11502452 |
31 | Encephalitis (HP:0002383) | 3.09888102 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02935558 |
33 | Obstructive lung disease (HP:0006536) | 3.02935558 |
34 | Hemoptysis (HP:0002105) | 3.02302593 |
35 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.01650915 |
36 | Recurrent viral infections (HP:0004429) | 2.99937651 |
37 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98618599 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98618599 |
39 | Hydroureter (HP:0000072) | 2.98410692 |
40 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97983917 |
41 | Abnormality of T cell number (HP:0011839) | 2.96597927 |
42 | Gastrointestinal inflammation (HP:0004386) | 2.93143494 |
43 | T lymphocytopenia (HP:0005403) | 2.92762260 |
44 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.91435883 |
45 | Flat acetabular roof (HP:0003180) | 2.90375497 |
46 | Arterial thrombosis (HP:0004420) | 2.88661515 |
47 | Abnormality of macrophages (HP:0004311) | 2.88576310 |
48 | Recurrent skin infections (HP:0001581) | 2.87873878 |
49 | Autoimmune thrombocytopenia (HP:0001973) | 2.87821467 |
50 | Systemic lupus erythematosus (HP:0002725) | 2.87727761 |
51 | Glomerulonephritis (HP:0000099) | 2.85827356 |
52 | Keratoconjunctivitis sicca (HP:0001097) | 2.84761396 |
53 | Bifid scrotum (HP:0000048) | 2.82189856 |
54 | Cheilitis (HP:0100825) | 2.75795258 |
55 | Gastrointestinal infarctions (HP:0005244) | 2.74502793 |
56 | Plantar hyperkeratosis (HP:0007556) | 2.74385267 |
57 | Abnormality of the renal collecting system (HP:0004742) | 2.73747710 |
58 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.73675567 |
59 | Recurrent bronchitis (HP:0002837) | 2.70490693 |
60 | Chest pain (HP:0100749) | 2.69802920 |
61 | Abnormal tarsal ossification (HP:0008369) | 2.68982587 |
62 | Down-sloping shoulders (HP:0200021) | 2.68424549 |
63 | Keratoconjunctivitis (HP:0001096) | 2.68223123 |
64 | Eczematoid dermatitis (HP:0000976) | 2.60550181 |
65 | Synostosis involving the elbow (HP:0003938) | 2.59703557 |
66 | Humeroradial synostosis (HP:0003041) | 2.59703557 |
67 | Hematochezia (HP:0002573) | 2.59399953 |
68 | Abnormality of T cells (HP:0002843) | 2.58764144 |
69 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.56841676 |
70 | Spontaneous hematomas (HP:0007420) | 2.56175233 |
71 | Hepatoblastoma (HP:0002884) | 2.55695157 |
72 | Pulmonary embolism (HP:0002204) | 2.52901175 |
73 | Chronic otitis media (HP:0000389) | 2.52839078 |
74 | Fragile nails (HP:0001808) | 2.52335514 |
75 | Leukocytosis (HP:0001974) | 2.51488867 |
76 | Restrictive lung disease (HP:0002091) | 2.50877877 |
77 | Cellulitis (HP:0100658) | 2.50485523 |
78 | Vacuolated lymphocytes (HP:0001922) | 2.49461635 |
79 | Submucous cleft hard palate (HP:0000176) | 2.46846044 |
80 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.46250820 |
81 | Hypoplastic scapulae (HP:0000882) | 2.46250820 |
82 | Abnormality of the pleura (HP:0002103) | 2.44109829 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43951529 |
84 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.42874490 |
85 | Urticaria (HP:0001025) | 2.42732219 |
86 | Chronic diarrhea (HP:0002028) | 2.42211339 |
87 | Long foot (HP:0001833) | 2.41542268 |
88 | Atrophic scars (HP:0001075) | 2.41497977 |
89 | True hermaphroditism (HP:0010459) | 2.41113999 |
90 | Autoimmune hemolytic anemia (HP:0001890) | 2.38953911 |
91 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.37372619 |
92 | Aplasia of the phalanges of the hand (HP:0009802) | 2.37372619 |
93 | Aplasia involving bones of the extremities (HP:0009825) | 2.37372619 |
94 | Abnormality of the fovea (HP:0000493) | 2.35438654 |
95 | Osteomyelitis (HP:0002754) | 2.33268686 |
96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33182957 |
97 | Absent/shortened dynein arms (HP:0200106) | 2.33182957 |
98 | Abnormality of eosinophils (HP:0001879) | 2.32592413 |
99 | Epistaxis (HP:0000421) | 2.32505284 |
100 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.31006596 |
101 | Abnormal foot bone ossification (HP:0010675) | 2.30058852 |
102 | Nasolacrimal duct obstruction (HP:0000579) | 2.29928424 |
103 | Optic neuritis (HP:0100653) | 2.29764756 |
104 | Retrobulbar optic neuritis (HP:0100654) | 2.29764756 |
105 | Granulocytopenia (HP:0001913) | 2.29003914 |
106 | Dysostosis multiplex (HP:0000943) | 2.28766512 |
107 | IgM deficiency (HP:0002850) | 2.28016389 |
108 | Abnormal glucose tolerance (HP:0001952) | 2.27666692 |
109 | Gangrene (HP:0100758) | 2.27170735 |
110 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26974039 |
111 | Abnormal pancreas size (HP:0012094) | 2.22833789 |
112 | IgG deficiency (HP:0004315) | 2.22765101 |
113 | Eosinophilia (HP:0001880) | 2.21106723 |
114 | Pulmonary fibrosis (HP:0002206) | 2.21035019 |
115 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.20862864 |
116 | Abnormality of B cell number (HP:0010975) | 2.20278765 |
117 | Abnormality of T cell physiology (HP:0011840) | 2.19680000 |
118 | Hypoplasia of the fovea (HP:0007750) | 2.19289619 |
119 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.19289619 |
120 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.19182231 |
121 | Stillbirth (HP:0003826) | 2.19153185 |
122 | Pustule (HP:0200039) | 2.18617057 |
123 | Abnormal ciliary motility (HP:0012262) | 2.16378234 |
124 | Bronchitis (HP:0012387) | 2.14272118 |
125 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.13061499 |
126 | Tubulointerstitial nephritis (HP:0001970) | 2.12953364 |
127 | Popliteal pterygium (HP:0009756) | 2.12207488 |
128 | Polyneuropathy (HP:0001271) | 2.11343542 |
129 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.10702054 |
130 | Lymphopenia (HP:0001888) | 2.10195027 |
131 | Cupped ear (HP:0000378) | 2.09049387 |
132 | Papilloma (HP:0012740) | 2.08898716 |
133 | Verrucae (HP:0200043) | 2.08898716 |
134 | Abnormality of male internal genitalia (HP:0000022) | 2.08570088 |
135 | Fibular aplasia (HP:0002990) | 2.07559637 |
136 | Median cleft lip (HP:0000161) | 2.07409835 |
137 | Long clavicles (HP:0000890) | 2.06425572 |
138 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.05377201 |
139 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.05377201 |
140 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04684753 |
141 | Renal cortical cysts (HP:0000803) | 2.04503350 |
142 | Upper limb muscle weakness (HP:0003484) | 2.04234091 |
143 | Thrombocytosis (HP:0001894) | 2.02887256 |
144 | Orchitis (HP:0100796) | 2.02825248 |
145 | Vertigo (HP:0002321) | 2.02440994 |
146 | Acute hepatic failure (HP:0006554) | 2.01709037 |
147 | Skin rash (HP:0000988) | 2.01592789 |
148 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01227545 |
149 | Metaphyseal irregularity (HP:0003025) | 2.00636766 |
150 | Prolonged bleeding time (HP:0003010) | 2.00531535 |
151 | Absent eyebrow (HP:0002223) | 1.99039301 |
152 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98928289 |
153 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98928289 |
154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98928289 |
155 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98113965 |
156 | Abnormality of the lacrimal duct (HP:0011481) | 1.97606442 |
157 | Recurrent pneumonia (HP:0006532) | 1.97406183 |
158 | Abnormality of cochlea (HP:0000375) | 1.95852267 |
159 | Abnormality of incisor morphology (HP:0011063) | 1.93479998 |
160 | Hypoplasia of dental enamel (HP:0006297) | 1.93053564 |
161 | Periauricular skin pits (HP:0100277) | 1.92040718 |
162 | Preauricular pit (HP:0004467) | 1.92040718 |
163 | Advanced eruption of teeth (HP:0006288) | 1.90348049 |
164 | Male pseudohermaphroditism (HP:0000037) | 1.88500998 |
165 | Palmar hyperkeratosis (HP:0010765) | 1.87629031 |
166 | Neonatal hypoglycemia (HP:0001998) | 1.87526497 |
167 | Abnormal blistering of the skin (HP:0008066) | 1.84495817 |
168 | Abnormality of the prostate (HP:0008775) | 1.83420374 |
169 | Sparse scalp hair (HP:0002209) | 1.83206365 |
170 | Abnormal sex determination (HP:0012244) | 1.82942615 |
171 | Sex reversal (HP:0012245) | 1.82942615 |
172 | Abnormality of the nasal septum (HP:0000419) | 1.82009043 |
173 | Abnormality of the nasolacrimal system (HP:0000614) | 1.81107854 |
174 | Natal tooth (HP:0000695) | 1.80086669 |
175 | Mediastinal lymphadenopathy (HP:0100721) | 1.79019517 |
176 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.78808617 |
177 | Short nail (HP:0001799) | 1.77373641 |
178 | White forelock (HP:0002211) | 1.77302849 |
179 | Morphological abnormality of the middle ear (HP:0008609) | 1.77275424 |
180 | Abnormality of carpal bone ossification (HP:0006257) | 1.76836824 |
181 | Alopecia of scalp (HP:0002293) | 1.75175268 |
182 | Germ cell neoplasia (HP:0100728) | 1.75101724 |
183 | Thick nail (HP:0001805) | 1.74954252 |
184 | Chromsome breakage (HP:0040012) | 1.74890530 |
185 | Tarsal synostosis (HP:0008368) | 1.74301564 |
186 | Ridged nail (HP:0001807) | 1.73943453 |
187 | Stenosis of the external auditory canal (HP:0000402) | 1.73841291 |
188 | Chronic sinusitis (HP:0011109) | 1.71023351 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 4.67070696 |
2 | ZAK | 4.55658235 |
3 | ERBB3 | 4.37512909 |
4 | MAP4K1 | 3.41477589 |
5 | TAOK3 | 3.32397877 |
6 | RIPK4 | 3.25630067 |
7 | TRPM7 | 3.03399246 |
8 | FRK | 2.95831886 |
9 | KIT | 2.89138577 |
10 | IRAK3 | 2.70831402 |
11 | CSF1R | 2.57257750 |
12 | IRAK4 | 2.48900924 |
13 | BLK | 2.40182156 |
14 | FES | 2.35118041 |
15 | NUAK1 | 2.31529495 |
16 | EPHB2 | 2.26367859 |
17 | MAP3K14 | 2.21169102 |
18 | SYK | 2.19651265 |
19 | MAP3K3 | 2.18167018 |
20 | ERN1 | 2.12302276 |
21 | TBK1 | 2.05092037 |
22 | MAP3K13 | 1.97890118 |
23 | MATK | 1.90179567 |
24 | MAPK15 | 1.88664304 |
25 | STK38L | 1.86292546 |
26 | PIK3CG | 1.78222501 |
27 | SIK3 | 1.72146927 |
28 | BMPR2 | 1.71141364 |
29 | MAP3K12 | 1.68626843 |
30 | MKNK2 | 1.63268072 |
31 | INSRR | 1.62339686 |
32 | MST4 | 1.61765700 |
33 | TESK2 | 1.60172842 |
34 | SGK2 | 1.58140901 |
35 | NEK6 | 1.52693253 |
36 | ITK | 1.52079283 |
37 | NLK | 1.51785307 |
38 | HIPK2 | 1.50334530 |
39 | CASK | 1.48001940 |
40 | LYN | 1.47406973 |
41 | PBK | 1.47213493 |
42 | MAP3K2 | 1.45667157 |
43 | HCK | 1.45242167 |
44 | RIPK1 | 1.40575810 |
45 | EIF2AK3 | 1.39959413 |
46 | ZAP70 | 1.39421919 |
47 | GRK7 | 1.39330311 |
48 | BMPR1B | 1.39044081 |
49 | CSK | 1.38377959 |
50 | TNK2 | 1.37050963 |
51 | GRK6 | 1.34223410 |
52 | TGFBR2 | 1.33767195 |
53 | LCK | 1.26696788 |
54 | AKT3 | 1.20736193 |
55 | MAP2K2 | 1.18576310 |
56 | PRKG2 | 1.16985273 |
57 | MARK3 | 1.14320836 |
58 | TXK | 1.14233770 |
59 | FLT3 | 1.12055678 |
60 | TLK1 | 1.03642139 |
61 | IRAK1 | 1.02673441 |
62 | CDK8 | 1.00102880 |
63 | EPHA3 | 0.99110953 |
64 | STK16 | 0.97308235 |
65 | JAK2 | 0.95595614 |
66 | SGK223 | 0.94425879 |
67 | SGK494 | 0.94425879 |
68 | SIK2 | 0.94026978 |
69 | CDK19 | 0.93212514 |
70 | PRKCQ | 0.91579320 |
71 | SGK3 | 0.90920205 |
72 | MST1R | 0.90807946 |
73 | IKBKE | 0.89245308 |
74 | ACVR1B | 0.88047899 |
75 | MKNK1 | 0.87240767 |
76 | RPS6KB2 | 0.87156757 |
77 | PINK1 | 0.86920121 |
78 | ADRBK2 | 0.84370473 |
79 | MAPKAPK5 | 0.83268080 |
80 | PRPF4B | 0.81378769 |
81 | TAOK2 | 0.81004175 |
82 | CHUK | 0.80150524 |
83 | ERBB4 | 0.78353825 |
84 | FER | 0.75780565 |
85 | TEC | 0.74986541 |
86 | MYLK | 0.72968611 |
87 | IKBKB | 0.72812390 |
88 | TNIK | 0.72148122 |
89 | TESK1 | 0.71599098 |
90 | BCKDK | 0.71573512 |
91 | JAK3 | 0.70975001 |
92 | TYK2 | 0.68109924 |
93 | FGR | 0.67493504 |
94 | IRAK2 | 0.67203524 |
95 | BTK | 0.66934467 |
96 | ERBB2 | 0.66563368 |
97 | CDC42BPA | 0.65861326 |
98 | FGFR3 | 0.65311224 |
99 | MAP4K2 | 0.63711780 |
100 | GRK1 | 0.62019381 |
101 | MAPK7 | 0.60230961 |
102 | RPS6KA2 | 0.60005069 |
103 | PIM1 | 0.57819579 |
104 | MAP2K7 | 0.57669614 |
105 | RPS6KL1 | 0.57307382 |
106 | RPS6KC1 | 0.57307382 |
107 | KDR | 0.56615566 |
108 | PRKCE | 0.54470585 |
109 | IGF1R | 0.54405083 |
110 | MAP3K7 | 0.54038486 |
111 | RPS6KA6 | 0.53923356 |
112 | MAPK11 | 0.53707236 |
113 | MAP2K1 | 0.53459797 |
114 | PDK1 | 0.53153822 |
115 | PIK3CA | 0.52454659 |
116 | MAP3K1 | 0.51490502 |
117 | EIF2AK2 | 0.51400400 |
118 | CDK3 | 0.51065575 |
119 | OXSR1 | 0.49127155 |
120 | STK24 | 0.47987178 |
121 | EGFR | 0.47490736 |
122 | PRKD2 | 0.47441257 |
123 | YES1 | 0.47213595 |
124 | FYN | 0.46726561 |
125 | CSNK1A1L | 0.46373849 |
126 | PDK2 | 0.45736404 |
127 | MAP2K3 | 0.45124692 |
128 | DAPK2 | 0.45070294 |
129 | MARK2 | 0.43441740 |
130 | MAPKAPK3 | 0.43186491 |
131 | CAMK2B | 0.43083558 |
132 | TTK | 0.41884215 |
133 | STK10 | 0.41835124 |
134 | NME2 | 0.41523507 |
135 | PRKCI | 0.41310846 |
136 | ABL1 | 0.40442857 |
137 | CDK6 | 0.39825140 |
138 | MAP2K6 | 0.39816243 |
139 | MAPKAPK2 | 0.39775871 |
140 | CAMKK2 | 0.39182987 |
141 | ATR | 0.38741782 |
142 | CLK1 | 0.38288270 |
143 | CAMK2G | 0.38183244 |
144 | PIM2 | 0.38010238 |
145 | RPS6KA4 | 0.35883201 |
146 | NEK9 | 0.35568146 |
147 | MAPK12 | 0.33923898 |
148 | INSR | 0.33815557 |
149 | EPHB1 | 0.32915989 |
150 | MAPK3 | 0.31266281 |
151 | PRKCD | 0.31265472 |
152 | CAMK2D | 0.30916200 |
153 | JAK1 | 0.30491106 |
154 | BRD4 | 0.27716099 |
155 | CSNK1A1 | 0.27608944 |
156 | STK11 | 0.27591182 |
157 | CSNK1G1 | 0.27004932 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.94213478 |
2 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.69300381 |
3 | Asthma_Homo sapiens_hsa05310 | 4.48114766 |
4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.13833950 |
5 | Glutathione metabolism_Homo sapiens_hsa00480 | 3.81824107 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.42028256 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.20230073 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.16961629 |
9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.83695335 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47844388 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27353746 |
12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20782660 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20410813 |
14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12783770 |
15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.07318615 |
16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93837454 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.87308706 |
18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.84084851 |
19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74991679 |
20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68337968 |
21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65927292 |
22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62090152 |
23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.52708062 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50512473 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49680725 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35437102 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32206022 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.31393196 |
29 | Pertussis_Homo sapiens_hsa05133 | 1.29503878 |
30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22632078 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19187761 |
32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17399486 |
33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11083197 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10480903 |
35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10053099 |
36 | Malaria_Homo sapiens_hsa05144 | 1.08439552 |
37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07836687 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04195876 |
39 | ABC transporters_Homo sapiens_hsa02010 | 1.03063237 |
40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99468853 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98620663 |
42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94526245 |
43 | Legionellosis_Homo sapiens_hsa05134 | 0.94282709 |
44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93253472 |
45 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92384226 |
46 | Measles_Homo sapiens_hsa05162 | 0.91948373 |
47 | Adherens junction_Homo sapiens_hsa04520 | 0.91871137 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91542740 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88784745 |
50 | Influenza A_Homo sapiens_hsa05164 | 0.88312212 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87230361 |
52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86449093 |
53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84546017 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.84150947 |
55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83908446 |
56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82857156 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78893233 |
58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78032318 |
59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.77454930 |
60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.76074241 |
61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75181908 |
62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74156863 |
63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73688347 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72835373 |
65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69150689 |
66 | Protein export_Homo sapiens_hsa03060 | 0.69001660 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.68511064 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.67162596 |
69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66678646 |
70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64851191 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64507280 |
72 | Tuberculosis_Homo sapiens_hsa05152 | 0.64420883 |
73 | Mineral absorption_Homo sapiens_hsa04978 | 0.63595247 |
74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62427950 |
75 | Prostate cancer_Homo sapiens_hsa05215 | 0.61426925 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60747042 |
77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60022440 |
78 | Amoebiasis_Homo sapiens_hsa05146 | 0.59659612 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59587816 |
80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57865748 |
81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56981339 |
82 | Salmonella infection_Homo sapiens_hsa05132 | 0.56353445 |
83 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55931241 |
84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55399526 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53321679 |
86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53160204 |
87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51895366 |
88 | RNA degradation_Homo sapiens_hsa03018 | 0.51270026 |
89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50477592 |
90 | Allograft rejection_Homo sapiens_hsa05330 | 0.50338529 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48530613 |
92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45768256 |
93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44024314 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43786776 |
95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43531986 |
96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42497889 |
97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42437175 |
98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40807018 |
99 | Hepatitis B_Homo sapiens_hsa05161 | 0.40760424 |
100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40229777 |
101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39611616 |
102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39610959 |
103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39346140 |
104 | Apoptosis_Homo sapiens_hsa04210 | 0.38328292 |
105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37850890 |
106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37504114 |
107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34795938 |
108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34782940 |
109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34761314 |
110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34618017 |
111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34583581 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34146805 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32233052 |
114 | Phototransduction_Homo sapiens_hsa04744 | 0.31696558 |
115 | Salivary secretion_Homo sapiens_hsa04970 | 0.31162330 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30754836 |
117 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.30556414 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30252407 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30199927 |
120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30061418 |
121 | Tight junction_Homo sapiens_hsa04530 | 0.29426531 |
122 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29399180 |
123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28929061 |
124 | Prion diseases_Homo sapiens_hsa05020 | 0.27903024 |
125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27574498 |
126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.27115266 |
127 | Renin secretion_Homo sapiens_hsa04924 | 0.26814842 |
128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24630077 |
129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24098934 |
130 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23750390 |
131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23085878 |
132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22954909 |
133 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.22724356 |
134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22294861 |
135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20894760 |
136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20303133 |
137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19023262 |
138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17563652 |
139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16954382 |
140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16300984 |
141 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.13789444 |
142 | Insulin resistance_Homo sapiens_hsa04931 | 0.13468838 |
143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12843451 |
144 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.12785282 |
145 | Shigellosis_Homo sapiens_hsa05131 | 0.11803679 |